annual accounts payable:
$15.18M+$545.00K(+3.72%)Summary
- As of today (September 15, 2025), AKBA annual accounts payable is $15.18 million, with the most recent change of +$545.00 thousand (+3.72%) on December 31, 2024.
- During the last 3 years, AKBA annual accounts payable has fallen by -$18.41 million (-54.81%).
- AKBA annual accounts payable is now -64.53% below its all-time high of $42.80 million, reached on December 31, 2018.
Performance
AKBA Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$11.55M-$1.10M(-8.72%)Summary
- As of today (September 15, 2025), AKBA quarterly accounts payable is $11.55 million, with the most recent change of -$1.10 million (-8.72%) on June 1, 2025.
- Over the past year, AKBA quarterly accounts payable has increased by +$1.45 million (+14.32%).
- AKBA quarterly accounts payable is now -82.05% below its all-time high of $64.36 million, reached on September 30, 2019.
Performance
AKBA quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AKBA Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.7% | +14.3% |
| 3 y3 years | -54.8% | -53.7% |
| 5 y5 years | -61.3% | -51.4% |
AKBA Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -54.8% | +3.7% | -53.7% | +27.8% |
| 5 y | 5-year | -63.3% | +3.7% | -72.5% | +27.8% |
| alltime | all time | -64.5% | >+9999.0% | -82.0% | >+9999.0% |
AKBA Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $11.55M(-8.7%) |
| Mar 2025 | - | $12.66M(-16.6%) |
| Dec 2024 | $15.18M(+3.7%) | $15.18M(+12.5%) |
| Sep 2024 | - | $13.49M(+33.5%) |
| Jun 2024 | - | $10.11M(-14.9%) |
| Mar 2024 | - | $11.88M(-18.8%) |
| Dec 2023 | $14.63M(-18.8%) | $14.63M(+61.9%) |
| Sep 2023 | - | $9.04M(-23.3%) |
| Jun 2023 | - | $11.78M(-6.4%) |
| Mar 2023 | - | $12.58M(-30.2%) |
| Dec 2022 | $18.02M(-46.3%) | $18.02M(-8.6%) |
| Sep 2022 | - | $19.71M(-21.0%) |
| Jun 2022 | - | $24.94M(+28.1%) |
| Mar 2022 | - | $19.47M(-42.0%) |
| Dec 2021 | $33.59M(-18.7%) | $33.59M(+16.6%) |
| Sep 2021 | - | $28.81M(-31.4%) |
| Jun 2021 | - | $41.98M(+37.5%) |
| Mar 2021 | - | $30.54M(-26.1%) |
| Dec 2020 | $41.31M(+5.3%) | $41.31M(+2.2%) |
| Sep 2020 | - | $40.40M(+70.0%) |
| Jun 2020 | - | $23.76M(-56.3%) |
| Mar 2020 | - | $54.38M(+38.7%) |
| Dec 2019 | $39.22M | $39.22M(-39.1%) |
| Sep 2019 | - | $64.36M(+233.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2019 | - | $19.32M(+26.9%) |
| Mar 2019 | - | $15.23M(-64.4%) |
| Dec 2018 | $42.80M(+511.5%) | $42.80M(+237.4%) |
| Sep 2018 | - | $12.68M(+164.5%) |
| Jun 2018 | - | $4.79M(-73.2%) |
| Mar 2018 | - | $17.88M(+155.5%) |
| Dec 2017 | $7.00M(>+9900.0%) | $7.00M(-19.6%) |
| Sep 2017 | - | $8.71M(-14.8%) |
| Jun 2017 | - | $10.21M(>+9900.0%) |
| Mar 2017 | - | $0.00(0.0%) |
| Dec 2016 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00(0.0%) |
| Jun 2016 | - | $0.00(0.0%) |
| Mar 2016 | - | $0.00(0.0%) |
| Dec 2015 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2015 | - | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) |
| Mar 2015 | - | $0.00(0.0%) |
| Dec 2014 | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2014 | - | $3.03M(+103.7%) |
| Jun 2014 | - | $1.49M(-28.4%) |
| Mar 2014 | - | $2.08M(>+9900.0%) |
| Dec 2013 | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2012 | $0.00 | - |
| Dec 2012 | - | $0.00 |
FAQ
- What is Akebia Therapeutics, Inc. annual accounts payable?
- What is the all time high annual accounts payable for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual accounts payable year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly accounts payable?
- What is the all time high quarterly accounts payable for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly accounts payable year-on-year change?
What is Akebia Therapeutics, Inc. annual accounts payable?
The current annual accounts payable of AKBA is $15.18M
What is the all time high annual accounts payable for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual accounts payable is $42.80M
What is Akebia Therapeutics, Inc. annual accounts payable year-on-year change?
Over the past year, AKBA annual accounts payable has changed by +$545.00K (+3.72%)
What is Akebia Therapeutics, Inc. quarterly accounts payable?
The current quarterly accounts payable of AKBA is $11.55M
What is the all time high quarterly accounts payable for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly accounts payable is $64.36M
What is Akebia Therapeutics, Inc. quarterly accounts payable year-on-year change?
Over the past year, AKBA quarterly accounts payable has changed by +$1.45M (+14.32%)